Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Juvenile | 12 | 2022 | 32 | 3.190 |
Why?
|
| Rheumatology | 6 | 2022 | 39 | 1.300 |
Why?
|
| Fibromyalgia | 2 | 2022 | 16 | 1.200 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 257 | 1.040 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2022 | 235 | 0.900 |
Why?
|
| Antirheumatic Agents | 5 | 2022 | 61 | 0.800 |
Why?
|
| Pediatrics | 2 | 2019 | 399 | 0.770 |
Why?
|
| Pharmaceutical Services | 1 | 2022 | 9 | 0.750 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2022 | 4 | 0.730 |
Why?
|
| Child | 16 | 2024 | 7621 | 0.720 |
Why?
|
| Uveitis | 4 | 2022 | 35 | 0.710 |
Why?
|
| Chronic Pain | 1 | 2022 | 186 | 0.610 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2019 | 23 | 0.600 |
Why?
|
| Biological Products | 1 | 2022 | 179 | 0.600 |
Why?
|
| Sjogren's Syndrome | 1 | 2019 | 34 | 0.600 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 52 | 0.590 |
Why?
|
| Adolescent | 13 | 2024 | 9878 | 0.540 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 21 | 0.520 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2022 | 21 | 0.360 |
Why?
|
| Humans | 26 | 2024 | 95992 | 0.320 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 492 | 0.240 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2023 | 60 | 0.240 |
Why?
|
| Ovarian Cysts | 1 | 2005 | 17 | 0.240 |
Why?
|
| Femoral Neoplasms | 1 | 2005 | 19 | 0.240 |
Why?
|
| Teratoma | 1 | 2005 | 58 | 0.230 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 101 | 0.220 |
Why?
|
| Antibodies, Antinuclear | 2 | 2015 | 95 | 0.220 |
Why?
|
| Drug Hypersensitivity Syndrome | 1 | 2024 | 3 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 326 | 0.220 |
Why?
|
| Osteosarcoma | 1 | 2005 | 160 | 0.220 |
Why?
|
| Abdominal Pain | 1 | 2005 | 145 | 0.210 |
Why?
|
| Interleukin-1 | 1 | 2024 | 71 | 0.210 |
Why?
|
| Glucocorticoids | 4 | 2022 | 369 | 0.200 |
Why?
|
| Interleukin-6 | 1 | 2024 | 281 | 0.190 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 75 | 0.190 |
Why?
|
| Mycophenolic Acid | 1 | 2022 | 86 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2022 | 71 | 0.180 |
Why?
|
| Medication Adherence | 1 | 2022 | 122 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 348 | 0.170 |
Why?
|
| Withholding Treatment | 2 | 2019 | 121 | 0.170 |
Why?
|
| Pain Measurement | 1 | 2022 | 378 | 0.170 |
Why?
|
| Dermatomyositis | 1 | 2020 | 20 | 0.160 |
Why?
|
| Myocarditis | 1 | 2020 | 62 | 0.160 |
Why?
|
| Parotid Gland | 1 | 2019 | 26 | 0.150 |
Why?
|
| S100A12 Protein | 1 | 2019 | 10 | 0.150 |
Why?
|
| Calgranulin A | 1 | 2019 | 11 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 800 | 0.150 |
Why?
|
| Calgranulin B | 1 | 2019 | 16 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2019 | 138 | 0.140 |
Why?
|
| Depression | 1 | 2022 | 562 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2019 | 281 | 0.140 |
Why?
|
| United States | 6 | 2022 | 7785 | 0.140 |
Why?
|
| Cytokines | 1 | 2022 | 871 | 0.130 |
Why?
|
| Induction Chemotherapy | 1 | 2018 | 151 | 0.130 |
Why?
|
| Quality of Life | 5 | 2022 | 1816 | 0.130 |
Why?
|
| Inflammation | 1 | 2022 | 1063 | 0.120 |
Why?
|
| Takayasu Arteritis | 1 | 2015 | 5 | 0.120 |
Why?
|
| Risk Factors | 4 | 2023 | 5992 | 0.110 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 11 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 444 | 0.110 |
Why?
|
| Calcitonin | 1 | 2014 | 40 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 997 | 0.110 |
Why?
|
| Diphosphonates | 1 | 2014 | 38 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2860 | 0.100 |
Why?
|
| Young Adult | 2 | 2022 | 7034 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2014 | 131 | 0.100 |
Why?
|
| Bone Density | 1 | 2014 | 238 | 0.100 |
Why?
|
| Male | 7 | 2024 | 45792 | 0.090 |
Why?
|
| Female | 9 | 2024 | 49980 | 0.090 |
Why?
|
| Temporomandibular Joint | 2 | 2022 | 20 | 0.090 |
Why?
|
| Vitamin D | 1 | 2014 | 273 | 0.090 |
Why?
|
| Immunization | 2 | 2022 | 165 | 0.090 |
Why?
|
| Urban Population | 1 | 2012 | 240 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2024 | 3969 | 0.080 |
Why?
|
| Symptom Flare Up | 2 | 2019 | 12 | 0.070 |
Why?
|
| Torsion Abnormality | 1 | 2005 | 18 | 0.060 |
Why?
|
| Infarction | 1 | 2005 | 27 | 0.060 |
Why?
|
| Mucositis | 1 | 2005 | 18 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2005 | 91 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 113 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 712 | 0.060 |
Why?
|
| Infant | 2 | 2024 | 3359 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2005 | 291 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1741 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 156 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 286 | 0.040 |
Why?
|
| Anxiety | 1 | 2022 | 339 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 426 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2023 | 776 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 5593 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1561 | 0.040 |
Why?
|
| Life Tables | 1 | 2018 | 47 | 0.040 |
Why?
|
| Maintenance Chemotherapy | 1 | 2019 | 91 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 372 | 0.030 |
Why?
|
| Echocardiography | 1 | 2023 | 1010 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 559 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 936 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 789 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 905 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 9228 | 0.030 |
Why?
|
| Arthralgia | 1 | 2015 | 41 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 998 | 0.030 |
Why?
|
| Knee Joint | 1 | 2015 | 166 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 51 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 110 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 295 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2014 | 171 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 1931 | 0.020 |
Why?
|
| Adult | 2 | 2022 | 28636 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 4690 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 10307 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1880 | 0.020 |
Why?
|